R. R. Reddel

Proteomic-based stratification of intermediate-risk prostate cancer patients

The paper identifies an 18-protein signature from proteomic data to stratify intermediate-risk prostate cancer patients into low- and high-risk groups for biochemical recurrence.

Alternative Lengthening of Telomeres is not synonymous with mutations in ATRX/DAXX

The paper reanalyzes PCAWG data to show that ATRX/DAXX mutations are not reliable indicators of ALT and proposes a new classifier based on C-circle assays.